𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia

✍ Scribed by Porzsolt, F. ;Thom�, J. ;Uns�ld, M. ;Wolf, W. ;Obert, H. J. ;Kubanek, B. ;Heimpel, H.

Book ID
104720910
Publisher
Springer-Verlag
Year
1985
Weight
518 KB
Volume
51
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of rituximab in combination wit
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
✍ Monica Else; Nnenna Osuji; Francesco Forconi; Claire Dearden; Ilaria Del Giudice 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract ## BACKGROUND. The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall responses in greater than 85% of patients and a median progression‐free survival of up to 15 years. They continue to be effective at second‐ and even